According to data obtained from SmartTrak Medical Device and Wound Market Intelligence, in the fourth quarter of 2024 ( Q424), the US Cellular Tissue Product (CTP) / Skin Substitute market grew 64.0% over the third quarter of 2023 (Q323).
Three market leaders combined represent 43.5% of the market share. These 3 companies are:
- BioLab Sciences
- Legacy Medical
- Extremity Care
Dr. Fife is a world renowned wound care physician dedicated to improving patient outcomes through quality driven care. Please visit my blog at CarolineFifeMD.com and my Youtube channel at https://www.youtube.com/c/carolinefifemd/videos
The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.
Providers using these products TRULY care about patient care, they have so much clinical evidence
There is only 1 reason a provider would use any of these 3 products and sadly it is not because they care about their patients. When the website says product is dehydrated and terminally sterilized, but has a high ASP, there lies the answer.
Well these products have the clinical efficacy to support this usage, look at the labs studies they have produced!!